Open AccessElements of Nonpharmacologic Interventions That Prevent Progression of Heart Failure: A Meta‐Analysis
Author(s) -
Kozak Andrea T.,
RuckerWhitaker Cheryl,
Basu Sanjib,
Mendes de Leon Carlos F.,
Calvin James E.,
Grady Kathleen L.,
Richardson DeJuran,
Powell Lynda H.
Publication year - 2007
Publication title -
congestive heart failure
Language(s) - English
Resource type - Journals
eISSN - 1751-7133
pISSN - 1527-5299
DOI - 10.1111/j.1527-5299.2007.07236.x
Subject(s) - medicine , odds ratio , meta analysis , confidence interval , heart failure , odds , psycinfo , mortality rate , medline , logistic regression , political science , law
This review examined whether nonpharmacologic treatment was associated with reductions in all‐cause mortality and heart failure (HF) hospitalizations and investigated the effects of face‐to‐face contact and longer treatment duration on these outcomes. MEDLINE and PsycINFO databases were searched through June 2006 and bibliographies of potential articles were hand‐searched. Nonpharmacologic treatment was associated with significantly lower odds of HF hospitalizations (odds ratio [OR], 0.41; 95% confidence interval [CI], 0.30–0.56) and death (OR, 0.69; 95% CI, 0.56–0.85) compared with control treatment. Face‐to‐face contact was associated with significantly lower odds of HF hospitalization (OR, 0.42; 95% CI, 0.22–0.81; P <.05) and death (OR, 0.63; 95% CI, 0.44–0.91; P <.05) as compared with control treatment. Longer treatment duration (≥12 months) was associated with a 65% reduction in the rate of HF hospitalizations and a 36% reduction in death rate. Nonpharmacologic treatment featuring face‐to‐face contact is particularly effective in reducing HF hospitalization and all‐cause mortality rates.